Navigation Links
Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
Date:8/15/2012

PALO ALTO, Calif., Aug. 15, 2012 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced that it has become a supporter of a phase III study comparing radiosurgery with surgical resection for the treatment of early-stage, high-risk, operable non-small cell lung cancer.  The study, which will take place over the next eight years, will look at patients' overall, disease-free, and regional recurrence-free survival rates three years after treatment, and also adverse events and post-treatment quality of life measures.

Sponsored by the U.S. National Cancer Institute (NCI), the study is being overseen by the Alliance, an NCI-sponsored research cooperative that was formed in March 2011 from the merger of the American College of Surgeons Oncology Group (ACOSOG), Cancer and Leukemia Group B (CALGB), and the North Central Cancer Treatment Group (NCCTG).  Referred to as ACOSOG Z4099/RTOG1021, the study plans to accrue 420 patients over a five-year period.  The Study Chair is Hiran Fernando, M.D., Boston Medical Center, and the Study Co-Chair is Robert Timmerman, M.D., University of Texas Southwestern.  As of June 2012, there were 45 cancer treatment centers that had met all requirements for becoming credentialed to participate in the study.

"Varian is very pleased to support this important study," said Kolleen Kennedy, president of Varian's Oncology Systems business.  "To date, there have not been any prospective, randomized trials to compare the efficacy and toxicity of surgery to radiosurgery for high-risk operable early-stage lung cancer patients.  We anticipate that this trial could yield very useful information for making treatment decisions about these types of cases."

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes, digital detectors, and image processing workstations for X-ray imaging in medical, scientific, and industrial applications and also supplies high-energy X-ray devices for cargo screening and non-destructive testing applications.  Varian Medical Systems employs approximately 6,000 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.

Forward-Looking Statements

Except for historical information, this news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning possible actions or outcomes in the future, and any statements using the words or phrases: "will," "plans to," "anticipate," "could," and similar expressions, are forward-looking statements that involve risks and uncertainties, most of which are difficult to predict and are generally beyond our control, and could cause results to differ materially from those anticipated.  Such risks and uncertainties include risks associated with a negative finding as to the effectiveness of or outcomes associated with radiosurgery versus surgery, a failure to accrue sufficient numbers of patients for the study, and other risks described from time to time in the company's filings with the Securities and Exchange Commission, which by this reference are incorporated herein.  We undertake no obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

FOR INFORMATION CONTACT:
Varian Medical Systems, United States
Meryl Ginsberg, 650.424.6444
meryl.ginsberg@varian.com


'/>"/>
SOURCE Varian Medical Systems
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Erich R. Reinhardt Appointed to Board of Directors of Varian Medical Systems
2. Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of Stock through Calendar Year 2013
3. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
4. Researchers Discover All-Natural Weapon In The War Against Ovarian Cancer
5. Varian Medical Systems Reports Results for Third Quarter of Fiscal Year 2012
6. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
7. Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020
8. Varian X-Ray Products Business Launches On-Line Product Finder for Customers
9. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
10. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
11. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... India , May 25, 2016 ... Review, H1 2016"market research report that provides an ... with comparative analysis at various stages, therapeutics assessment ... of administration (RoA) and molecule type, along with ... It also reviews key players involved in the ...
(Date:5/24/2016)... , May 24, 2016  Diana Russell suffers ... her organs from the inside out.  This disease has ... dependent on her children and grandchildren to leave her ... wheelchair, Diana,s family cannot haul the wheelchair.  So if ... the car, and Diana is left to wait for ...
(Date:5/24/2016)... 2016 The innovator of ... , s first dual therapy stent, introduces catheters ... OrbusNeich, a global company specializing in the provision ... include products to treat peripheral artery disease. The JADE™ ... devices for lower limb and arteriovenous (AV) fistula intervention. ...
Breaking Medicine Technology:
(Date:5/25/2016)... ... May 25, 2016 , ... Cheryl Bowker of Bowker Insurance Group has been ... Good Hands Legacy Award. McKenna ran one of Allstate’s most successful agencies for 48 ... those who knew him. The award named for him is not given every year, ...
(Date:5/25/2016)... ... ... Afrimesure specializes in providing clients with ideal measurement and ... facilities. Their knowledgeable staff also takes care of the installation, IQ/OQ/PQ qualification protocols, ... variety of MadgeTech systems available for sterilization and temperature monitoring, including the software ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... the results of its annual Medical and Prescription Drug survey , an ... , The survey, which was conducted in December 2015, indicates that employers ...
(Date:5/25/2016)... ... ... than fifty years, we've suffered whiplash as each new scientific study seemed to contradict the ... advice – advice that was supposed to keep us healthy and slim. And what happened? ... considered to be overweight and more than 1 in 3 adults are considered to be ...
(Date:5/25/2016)... ... May 25, 2016 , ... ... seen a significant spike in their clients' employee participation for their wellness initiatives. ... screening by implementing a high-deductible health plan with outcome-based deductible incentives. As a ...
Breaking Medicine News(10 mins):